Latest / Markets & Money News Today | 2 Min News | THE DAILY NOW!
Nurix Therapeutics Earnings Rise, Shares Dip 2% | Markets & Money News
Nurix Therapeutics reported impressive Q3 earnings with revenue soaring to $673.1 million, up from $7.9 million last year. Adjusted earnings per share improved to $4.73, recovering from a loss of $1.03 in the previous year. A significant portion of revenue stemmed from a collaboration with Roche, contributing $653.2 million in license revenue. While R&D expenses decreased to $79.3 million, general and administrative costs rose due to one-time expenses related to the Roche deal. Nurix remains
www.TheDailyNewsNow.com
This is an automated, high-level news summary based on public reporting and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.